162 related articles for article (PubMed ID: 31828511)
21. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.
Nunnari G; Otero M; Dornadula G; Vanella M; Zhang H; Frank I; Pomerantz RJ
AIDS; 2002 Jan; 16(1):39-45. PubMed ID: 11741161
[TBL] [Abstract][Full Text] [Related]
22. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.
Bouchat S; Gatot JS; Kabeya K; Cardona C; Colin L; Herbein G; De Wit S; Clumeck N; Lambotte O; Rouzioux C; Rohr O; Van Lint C
AIDS; 2012 Jul; 26(12):1473-82. PubMed ID: 22555163
[TBL] [Abstract][Full Text] [Related]
23. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
Han Y; Lassen K; Monie D; Sedaghat AR; Shimoji S; Liu X; Pierson TC; Margolick JB; Siliciano RF; Siliciano JD
J Virol; 2004 Jun; 78(12):6122-33. PubMed ID: 15163705
[TBL] [Abstract][Full Text] [Related]
24. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
[TBL] [Abstract][Full Text] [Related]
25. CD4
Agosto LM; Henderson AJ
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):780-789. PubMed ID: 29869531
[TBL] [Abstract][Full Text] [Related]
26. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
[TBL] [Abstract][Full Text] [Related]
27. The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.
Conrad RJ; Fozouni P; Thomas S; Sy H; Zhang Q; Zhou MM; Ott M
Mol Cell; 2017 Sep; 67(6):1001-1012.e6. PubMed ID: 28844864
[TBL] [Abstract][Full Text] [Related]
28. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
29. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
Kaczmarek Michaels K; Natarajan M; Euler Z; Alter G; Viglianti G; Henderson AJ
J Immunol; 2015 Apr; 194(7):3267-74. PubMed ID: 25710909
[TBL] [Abstract][Full Text] [Related]
30. SUN2 Modulates HIV-1 Infection and Latency through Association with Lamin A/C To Maintain the Repressive Chromatin.
Sun WW; Jiao S; Sun L; Zhou Z; Jin X; Wang JH
mBio; 2018 May; 9(3):. PubMed ID: 29717016
[TBL] [Abstract][Full Text] [Related]
31. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
33. Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
Van der Sluis RM; Zerbato JM; Rhodes JW; Pascoe RD; Solomon A; Kumar NA; Dantanarayana AI; Tennakoon S; Dufloo J; McMahon J; Chang JJ; Evans VA; Hertzog PJ; Jakobsen MR; Harman AN; Lewin SR; Cameron PU
PLoS Pathog; 2020 Feb; 16(2):e1008151. PubMed ID: 32109259
[TBL] [Abstract][Full Text] [Related]
34. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
35. HIV reservoir dynamics in the face of highly active antiretroviral therapy.
Costiniuk CT; Jenabian MA
AIDS Patient Care STDS; 2015 Feb; 29(2):55-68. PubMed ID: 25412339
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
37. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
38. A unified concept of HIV latency.
Bagasra O
Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
[TBL] [Abstract][Full Text] [Related]
39. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
mBio; 2017 May; 8(3):. PubMed ID: 28465428
[TBL] [Abstract][Full Text] [Related]
40. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4
Grau-Expósito J; Serra-Peinado C; Miguel L; Navarro J; Curran A; Burgos J; Ocaña I; Ribera E; Torrella A; Planas B; Badía R; Castellví J; Falcó V; Crespo M; Buzon MJ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]